Reversible airway obstruction in children with ataxia telangiectasia

Pediatric Pulmonology

Volumn 45, Issue 3, 2010, Pages 230-235

  Berkun, Yackov ^a,b   Vilozni, Daphna ^a   Levi, Yonit ^a,b   Borik, Sheron ^a   Waldman, Dalia ^a   Somech, Raz ^a   Nissenkorn, Andreea ^a   Efrati, Ori ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Airway obstruction; Ataxia telangiectasia; Children

Indexed keywords

ANTIASTHMATIC AGENT; BRONCHODILATING AGENT; STEROID;

AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; ATAXIA TELANGIECTASIA; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DETERIORATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; MALE; PRIORITY JOURNAL; PROGNOSIS; SPIROMETRY; SYMPTOM; TREATMENT RESPONSE;

ADMINISTRATION, INHALATION; ADOLESCENT; ANTI-ASTHMATIC AGENTS; ASTHMA; ATAXIA TELANGIECTASIA; BRONCHODILATOR AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPIROMETRY; VITAL CAPACITY; YOUNG ADULT;

EID: 77449141190     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21095     Document Type: Article

References (26)

1. Uziel T, Savitsky K, Platzer M, Ziv Y, Helbitz T, Nehls M, Boehm T, Rosenthal A, Shiloh Y, Rotman G. Genomic organization of the ATM gene. Genomics 1996;33:317-320.
2. Rotman G, Shiloh Y. ATM: from gene to function. Hum Mol Genet 1998;7:1555-1563.
3. Savitsky K, Sfez S, Tagle DA, Ziv Y, Sartiel A, Collins FS, Shiloh Y, Rotman G. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet 1995;4:2025-2032.
4. Crawford TO, Skolasky RL, Fernandez R, Rosquist KJ, Lederman HM. Survival probability in ataxia telangiectasia. Arch Dis Child 2006;91:610-611.
5. Bott L, Lebreton J, Thumerelle C, Cuvellier J, Deschildre A, Sardet A. Lung disease in ataxia-telangiectasia. Acta Paediatr 2007;96:1021-1024.
6. Nowak-Wegrzyn A, Crawford TO, Winkelstein JA, Carson KA, Lederman HM. Immunodeficiency and infections in ataxia-telangiectasia. J Pediatr 2004;144:505-511.
7. Lefton-Greif MA, Crawford TO, Winkelstein JA, Loughlin GM, Koerner CB, Zahurak M, Lederman HM. Oropharyngeal dysphagia and aspiration in patients with ataxia-telangiectasia. J Pediatr 2000;136:225-231.
8. Schroeder SA, Swift M, Sandoval C, Langston C. Interstitial lung disease in patients with ataxia-telangiectasia. Pediatr Pulmonol 2005;39:537-543.
9. McGrath-Morrow S, Lefton-Greif M, Rosquist K, Crawford T, Kelly A, Zeitlin P, Carson KA, Lederman HM. Pulmonary function in adolescents with ataxia telangiectasia. Pediatr Pulmonol 2008;43:59-66.
10. Cabana MD, Crawford TO, Winkelstein JA, Christensen JR, Lederman HM. Consequences of the delayed diagnosis of ataxia-telangiectasia. Pediatrics 1998;102:98-100.
11. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CPM, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J. ATS/ERS task force: standardisation of lung function testing. Standardisation of spirometry. Eur Respir J 2005;26:319-333.
12. Polgar G, Promadhat V. 1971. Pulmonary function testing in children: techniques and standards. Philadelphia: W.B. Saunders.
13. Vilozni D, Barak A, Efrati O, Augarten A, Springer C, Yahav Y, Bentur L. The role of computer games in measuring spirometry in healthy and "asthmatic" preschool children. Chest 2005;128: 1146-1155.
14. National Asthma Education and Prevention/NIH/NHLBI. Practical guide for the diagnosis and management of asthma. 1998. Based on expert panel report 2: guidelines for the diagnosis and management of asthma. Bethesda: National Institutes of Health; 1997.
15. Teixeira BC, Norton RC, Penna FJ, Camargos PA, Lasmar LM, Macedo AV. Gastroesophageal reflux and asthma in childhood: a study on their relationship using esophageal PH monitoring. J Pediatr (Rio J) 2007;83:535-540.
16. McGrath-Morrow SA, Sterni L, McGinley B, Lefton-Greif MA, Rosquist K, Lederman H. Polysomnographic values in adolescents with ataxia telangiectasia. Pediatr Pulmonol 2008;43:674-679.
17. Alkhalil M, Schulman ES, Getsy J. Obstructive sleep apnea syndrome and asthma: the role of continuous positive airway pressure treatment. Ann Allergy Asthma Immunol 2008;101: 350-357.
18. Claret Teruel G, Giner Munoz MT, Plaza Martin AM, Martin Mateos MA, Piquer Gibert M, Sierra Martinez JI. Variability of immunodeficiency associated with ataxia telangiectasia and clinical evolution in 12 affected patients. Pediatr Allergy Immunol 2005;16:615-618.
19. Miller MR, Pedersen OF, Quanjer PH. The rise and dwell time for peak expiratory flow in patients with and without airflow limitation. Am J Respir Crit Care Med 1998;158:23-27.
20. Pedersen OF, Rasmussen TR, Kjaergaard SK, Miller MR, Quanjer PH. Frequency response of variable orifice type peak flow meters: requirements and testing. Eur Respir J 1995;8:849-855.
21. Gauld LM, Boynton A. Relationship between peak cough flow and spirometry in Duchenne muscular dystrophy. Pediatr Pulmonol 2005;39:457-460.
22. Galasko CS, Williamson JB, Delaney CM. Lung function in Duchenne muscular dystrophy. Eur Spine J 1995;4:263-267.
23. Gozal D. Pulmonary manifestations of neuromuscular disease with special reference to Duchenne muscular dystrophy and spinal muscular atrophy. Pediatr Pulmonol 2000;29:141-150.
24. Schramm CM. Current concepts of respiratory complications of neuromuscular disease in children. Curr Opin Pediatr 2000;12: 203-207.
25. Bach JR, Zhitnikov S. The management of neuromuscular ventilatory failure. Semin Pediatr Neurol 1998;5:92-105.
26. Olsen JH, Hahnemann JM, Borresen-Dale AL, Brondum-Nielsen K, Hammarstrom L, Kleinerman R, Kaariainen H, Lonnqvist T, Sankila R, Seersholm N, Tretli S, Yuen J, Boice JD, Jr., Tucker M. Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries. J Natl Cancer Inst 2001;93:121-127.